Search research articles
Contact Us
Filters
Showing results (381-390 of 456) with videos related to
Page
of 46
Sort By:
International Journal of Cancer
|
September 25, 2018
Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastoma
Sarah Harris-Bookman, Dimitrios Mathios, Allison M Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 18, 2009
Tc17 CD8 T cells: functional plasticity and subset diversity
Hung-Rong Yen, Timothy J Harris, Satoshi Wada, et al.
Nature Medicine
|
January 11, 2022
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial
Thomas Powles, Kobe C Yuen, Silke Gillessen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 7, 2013
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas
Jing Zeng, Alfred P See, Jillian Phallen, et al.
Journal for Immunotherapy of Cancer
|
December 30, 2016
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma
Douglas G McNeel, Neil H Bander, Tomasz M Beer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2021
Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer
Catherine H Marshall, Wei Fu, Hao Wang, et al.
Cancer Cell
|
April 28, 2023
Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators
Aleksandar Obradovic, Casey Ager, Mikko Turunen, et al.
European Urology
|
March 8, 2021
CD38 in Advanced Prostate Cancers
Christina Guo, Mateus Crespo, Bora Gurel, et al.
Kidney Cancer (Clifton, Va.)
|
October 19, 2018
Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path Forward
L C Harshman, C G Drake, N B Haas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates
Julie R Brahmer, Charles G Drake, Ira Wollner, et al.
Page
of 46
Search research articles
Search
Showing results (381-390 of 456) with videos related to
Sort By:
Page
of 46
International Journal of Cancer
|
September 25, 2018
Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastoma
Sarah Harris-Bookman, Dimitrios Mathios, Allison M Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 18, 2009
Tc17 CD8 T cells: functional plasticity and subset diversity
Hung-Rong Yen, Timothy J Harris, Satoshi Wada, et al.
Nature Medicine
|
January 11, 2022
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial
Thomas Powles, Kobe C Yuen, Silke Gillessen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 7, 2013
Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas
Jing Zeng, Alfred P See, Jillian Phallen, et al.
Journal for Immunotherapy of Cancer
|
December 30, 2016
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma
Douglas G McNeel, Neil H Bander, Tomasz M Beer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2021
Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer
Catherine H Marshall, Wei Fu, Hao Wang, et al.
Cancer Cell
|
April 28, 2023
Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators
Aleksandar Obradovic, Casey Ager, Mikko Turunen, et al.
European Urology
|
March 8, 2021
CD38 in Advanced Prostate Cancers
Christina Guo, Mateus Crespo, Bora Gurel, et al.
Kidney Cancer (Clifton, Va.)
|
October 19, 2018
Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path Forward
L C Harshman, C G Drake, N B Haas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates
Julie R Brahmer, Charles G Drake, Ira Wollner, et al.
Page
of 46